Trials / Completed
CompletedNCT05661591
Effect of Fluconazole on Pharmacokinetics of SHR2554 in Healthy Subjects
Pharmacokinetic Effect of Fluconazole on SHR2554 in Healthy Subjects in Single-center, Open-label, Single-dose, Auto-controlled Pharmacokinetics
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 18 (actual)
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
The study is being conduct to evaluate fluconazole effect of on SHR2554 in condition of single-canter, open-label, single-dose in healthy subjects. To explore the SHR2554 pharmacokinetics change under use of fluconazole and insure the safety with SHR2554 combined with fluconazole.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | SHR2554 Tablets | SHR2554 Tablets+ Fluconazole Capsules |
| DRUG | Fluconazole Capsules | SHR2554 Tablets+ Fluconazole Capsules |
Timeline
- Start date
- 2023-02-28
- Primary completion
- 2023-03-31
- Completion
- 2023-03-31
- First posted
- 2022-12-22
- Last updated
- 2023-04-04
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05661591. Inclusion in this directory is not an endorsement.